Close

Insmed (NSM) Doses First Patient in ARIKACE Phase 2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SNV
5. TSLA
6. SPY
7. INFY
8. SMCI
9. NVDA
10. SLB


Go back to Insmed (NSM) Doses First Patient in ARIKACE Phase 2
INSMED (NASDAQ: INSM) Delayed: 24.32 -0.48 (1.94%)
Previous Close $24.80    52 Week High $19.30 
Open $24.86    52 Week Low $9.02 
Day High $25.87    P/E N/A 
Day Low $23.53    EPS $-1.69 
Volume 5,534,189